Skip to search boxSkip to navigationSkip to main content

Adenosine receptor A2a deficiency in leukocytes increases arterial neointima formation in apolipoprotein E-deficient mice

  • Huan Wang
    ,
  • Weiyu Zhang
    ,
  • Rong Tang
    ,
  • Chuhong Zhu
    ,
  • Christoph Bucher
    ,
  • Bruce R. Blazar
*Corresponding author for this work
  • University of Minnesota Twin Cities
    ,
  • University of Medicine and Dentistry of New Jersey
    ,
  • University of Virginia
    ,
  • Texas A&M University
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

Objective-: To use the mice deficient in both adenosine receptor A2A (A2AR) and apolipoprotein E (apoE) to investigate the role of A2AR in mediating the interactions of leukocytes with injured arterial walls and the formation of arterial neointima induced by a guide wire.Methods and results-: In apoE mice, A2AR deficiency increased the size of the arterial neointima in injured carotid arteries by 83%. Arterial neointima formation was also enhanced in chimeric mice that underwent bone marrow transplantation (these mice lacked A2AR in their bone marrow-derived cells). Epifluorescence intravital microscopy showed that neutrophil rolling and adherence to the injured arterial area were enhanced by 80% and 110% in A2AR/apoE mice, respectively. This phenomenon occurred even though the protein levels of homing molecules on A2AR-deficient neutrophils were unchanged from those of wild-type neutrophils. A2AR-deficient neutrophils exhibited an increase in the phosphorylation of p38 mitogen-activated protein kinase, P-selectin glycoprotein ligand-1 (PSGL-1) clustering, and the affinity of b2 integrins. The inhibition of p38 phosphorylation abrogated the increased PSGL-1 clustering and β2 integrin affinity, thus reversing the increased homing ability of A2AR-deficient leukocytes. Conclusion-: A2AR plays a complex role in inflammation and tissue injury. The deficiency of A2AR enhances the homing ability of leukocytes and increases the formation of the arterial neointima after injury. A2AR antagonists are being tested for the treatment of neurodegenerative and other chronic diseases. An evaluation of the effect of A2AR antagonists on arterial restenosis after arterial angioplasty should be conducted.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 915-922 (8 pages)

Journal (Volume, Issue Number)

Arteriosclerosis, thrombosis, and vascular biology (Volume 30, Issue 5)

Publication milestones

  • Published - 05/2010

Publication status

Published - 05/2010

ISSN

1079-5642

Publication IDs

  • Scopus: 77951428632
  • PubMed: 20167656
  • ORCID: /0000-0002-0305-4122/work/124760194

Publication metrics

Metrics

SciVal
FWCI
1.01
SciVal
Author count
11
SciVal
citations
17
SciVal
Paper percentile
73
Scopus
citations
Fractional count
1
Fractional count
0.09
Fractional count
10
Fractional count
0.91
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
18
Citation count
16

Funding Details

FunderFunding numbers
NHLBI
R01HL080133, R01HL080569, R01HL078679, R01HL095707